Medy-Tox Inc. (KOSDAQ:086900)
South Korea · Delayed Price · Currency is KRW 64,100
-1,800 (-2.73%)
Oct 12, 2026, 3:30 PM KST
Medy-Tox Market Cap
Medy-Tox has a market cap or net worth of 413.97 billion as of October 12, 2026. It is the 18,101st most valuable company in the world and the 539th biggest in South Korea. Its market cap has decreased by 50.27% in one year.
Market Cap
413.97B
Enterprise Value
495.53B
Revenue
251.08B
Global Rank
Country Rank
#539 South Korea
PE Ratio
28.64
ChartMarket Cap Chart
Since January 16, 2009, Medy-Tox's market cap has increased from 71.73B to 413.97B, an increase of 477.17%. That is a compound annual growth rate of 10.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 413.97B | -51.18% |
| Dec 30, 2025 | 847.99B | 2.03% |
| Dec 30, 2024 | 831.10B | -48.75% |
| Dec 28, 2023 | 1.62T | 101.16% |
| Dec 29, 2022 | 806.18B | -7.99% |
| Dec 30, 2021 | 876.20B | -13.91% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Onconic Therapeutics | 675.21B |
| Hyundai Bioscience | 668.77B |
| GI Innovation | 545.81B |
| AbClon | 509.78B |
| Proteina | 489.96B |
| GC Corp. | 443.05B |
| Orum Therapeutics | 419.18B |
| MEDIPOST | 374.83B |